Baxter BioScience TOFX

2020-08-27T15:35:18+00:00

Baxter BioScience TOFX is a state-of-the-art hemophilia therapy production suite facility which manufactures recombinant Antihemophilic Factor (rAHF) – a clotting factor produced by recombinant DNA technology and used a treatment for the blood disorder hemophilia.

Go to Top